FDG-PET response predicts overall and disease free survival after induction chemotherapy with docetaxel (D) plus carboplatin (C) and erythropoietin (Epo) in locally advanced (Stage III) non-small cell lung cancer (NSCLC)
2004 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
FDG-PET response predicts overall and disease free survival after induction chemotherapy with docetaxel (D) plus carboplatin (C) and erythropoietin (Epo) in locally advanced (Stage III) non-small cell lung cancer (NSCLC)
Griesinger, F.; Criee, C. P.; Schoendube, F.; Schmidberger, H.; Andreas, S.; Schirren, J. & Hemmerlein, B. et al. (2004)
Annals of Oncology, 15
Oxford: Oxford Univ Press.
